About 2iM
Historic
2iM® was created, in 2011, from a spin-off of Impacto Tecnologia Geracionais em Saúde (Impacto Generational Health Technology). As soon as it was created, it went through a selection process at the Technological Incubator (INTEC) of the Paraná Institute of Technology and was approved without restriction. At the end of 2015 he graduated from the incubator and in 2017 it became a scale-up receiving an investment from the PRIMATEC Fund.
2iM’s value proposition is to use analytics tools to measure Health Value. For this value proposition, 2iM develops applications and systems for health data generation, uses interoperability techniques and solutions, generates specific metrics of quality and cost in health and implements new Value-based payment models.
In 2014 the company enshrined its assistance performance evaluation model, GPS.2iM©, initiating projects in large hospitals; today it is already in use in nearly 30% of ANAHP hospitals, with more than 40,000 doctors evaluated with this tool, in addition to being used by several public and private payers.
2iM is a reference in the market for evaluating the performance of doctors and healthcare services and for implementing Value-based payment models.
Business Definition
Using the Business Analytics (BA) concept, we group, analyze and track health information with a focus on strategic decision making in relation to your institution’s quality and health performance indicators. This concept is about the evolution of BI enabling access, tracking, storage, transformation, modeling, analysis and delivery of information with the main objective of enabling the strategic decision making of its management team and restructuring Value-based remuneration models.
- Mission
- Vision
- Values
Aggregate and generate information to measure Health Value, supporting the system so that it becomes sustainable and improves the quality of people's lives.
In 5 years to be a national reference to measure Health Value, maintaining impartiality and promoting the sustainability of the sector.
Integrity Social responsability Exemption Commitment to results Innovation
Team
DR. CÉSAR ABICALAFFE
JOSIANE JUSTUS
SOLANGE ABICALAFFE SERCI
Associated Consultants
DR. ANDRÉ MÉDICI
DR. ANDRÉ OSMO
DR. WALTER LYRIO DO VALLE
DR. MARCELO CUNIO MACHADO FONSECA, MD, PhD
GABRIELA TANNUS BRANCO DE ARAÚJO, MSc
ANDRÉ GUSTAVO DAHER VIANNA
JOÃO MARQUES GOMES
Partners
Gold trading partner.
Medical specialists for the development of DM.Analytics.
AKRIVOS
Medical specialists and relationship with the academy for MOM.
Medical specialists and consultants for some lines of care.
Value analysis model of associated hospitals and benchmarking.
Qualification of associates and benchmarking.
Partner institution in discussions on Value-Based Health.
Plataforma de referenciamento de mercado, que busca contribuir para a criação de um Sistema de Valor Sustentável e a evolução do Setor de Saúde.
Code of conduct
The essence of 2iM®’s business is the aggregation and integration of data from different players in the health field, whether public or private. Thus, the result of our work is the knowledge of sensitive data. In this sense, the 2iM® Code of Conduct establishes our line of conduct and the way we deal with this fact.
It aims to reinforce our values and principles, specifying our work conduct, especially with regard to the relationship with patients, clients and outsourced consultants, whether in the public or private area.
Following the main ethical, anti-corruption and transparency standards is our role and responsibility. Thus, we contribute to the good corporate governance of our company and our clients and partners by managing the risks relevant to our activity.
With patients We guarantee the confidentiality and secrecy of the personal data required by the Brazilian Constitution of 1988 in its fifth article. For the dissemination of results, we work with absolute data, preferably numerical and in acronyms so as not to individualize and detail personal statements. We do not disclose the patient's name, at most his initials and location. To avoid homonyms, or even research bias due to the fact that the patient changes doctors, we use the initials of the mother's name. We do not use sensitive information, such as the disease or signs and symptoms that the patient has, for his own purposes, to help any interested party or harm any other party. We recognize and respect that the patient is the only one entitled to disclose his confidential information or authorize (in writing) his disclosure. We do not work or take gifts or any item, of any value, that may appear to be a favor exchange. With doctors and other health service providers The data of doctors and other health service providers are not identified, at most including initials, city of service, region and specialty or type of provider. We recognize and respect that the physician is the guardian of patient information. We do not interfere with the treatment conduct established by the doctor. With the pharmaceutical industry We do not provide specific data or information from patients, doctors or other healthcare providers. In communication materials, our or clients', we respect the established by the norms in force in the country (RDC 96). We guarantee the secrecy and confidentiality of the strategic information obtained. We are custodians of any and all material delivered, original or copy, that contains confidential strategic information. At the end, we return, along with the work done, all the material delivered. With clients, public or private managers and strategic alliances We do not practice or encourage bribery and corruption. We do not take messages to third parties, whatever it may be. We do not provide specific patient or physician data or information. We seek to establish contracts, terms of responsibility and confidentiality in the work performed.
“Informação confidencial” significa informação de natureza ou propriedade confidencial de qualquer uma das partes reveladas à outra parte, incluindo questões de natureza técnica como segredos de negócio, métodos, protótipos, dados, ideias, designs, formulação, know-how e itens similares que poderão ser revelados e que não se configuram em informações públicas ou publicadas nem em fontes de negócio, além de qualquer outra informação designada pelo cliente e 2iM® como confidencial.
Os funcionários, parceiros e colaboradores em geral da 2iM® têm acesso a diversas informações de clientes da 2iM®: médicos, pacientes, dentre outros. Todas essas informações devem ser consideradas como “informações confidenciais” a todo o tempo e para todos os fins, sendo desautorizada sua revelação.
Trabalhamos com informações públicas e identificamos as fontes de pesquisas a fim de demonstrar e comprovar a origem das mesmas.
Garantimos e guardamos a confidencialidade por três anos após a entrega do trabalho e não utilizamos esses dados para outros trabalhos, respeitando a livre concorrência.
Não utilizamos as informações confidenciais para obter vantagens pessoais.
Não copiamos, transcrevemos, transmitimos informações confidenciais, sem prévio consentimento escrito das partes envolvidas.
Não empregamos ou contratamos, mesmo que para consultorias temporárias, profissionais submetidos à relação de funcionalismo público ou emprego dentro do governo, empresas estatais ou controladas por agências ou órgãos públicos (inclusive instituições médicas ou de saúde governamentais ou controladas pelo governo) cuja posição permita influência ou promoção indevida dos interesses de qualquer parte, especialmente no que tange a licitações e compras públicas.
Não empregamos ou contratamos menores de 18 anos e não incentivamos práticas que levem ao trabalho infantil.
Respeitamos as propriedades intelectuais dos autores e criadores.
Sempre que solicitado, fornecemos cópias dos recolhimentos dos tributos (INSS, ISS, PIS, Imposto de Renda, FGTS, Contribuição Sindical, dentre outros) e outros documentos que forem julgados necessários.
Devolvemos todos os materiais entregues a nós para realização do trabalho.
Trabalhamos e seguimos as normas reconhecidas como padrão de ética, transparência e respeito:
• “FCPA – Foreign Corruption Practices Act” (LEI DE PRÁTICAS DE CORRUPÇÃO NO EXTERIOR – DISPOSIÇÕES ANTISSUBORNO) Legislação dos Estados Unidos da América que se aplica a empresas com matriz naquele país e filiais em outros países;
• Lei 10467/2002, Lei 9613/1998, artigo 333 da Lei 2848/40 (Código Penal), Código de Conduta da Alta Administração Federal e Estatuto do Servidor Público Civil;
• Lei n° 3.268, de 30 de setembro de 1957, regulamentada pelo decreto n° 44.045, de 19 de julho de 1958, alterados pela Lei nº 11.000, de 15 de dezembro de 2004, e decreto nº 6.821, de 14 de abril de 2009;
• Art. 2º e Art. 15 da Lei nº 3.268/57;
• Art. 16 do decreto-Lei nº 20.931/32, alíneas c, g e h;
• Código de Ética Médica – Resolução CFM No. 1.931/09;
• Política do Cartão Nacional de Saúde CNS e sigilo sobre dados do paciente;
• Normas éticas de pesquisa CONEP e CEP.
Our Clients
